Abstract
Recent advances in antiretroviral therapies have enhanced survival of HIV/ AIDS patients, but cardiovascular complications have emerged as important issues in this growing patient population. Although the antiviral drug therapies apparently yield cardiac and/or vascular toxicities themselves, several other factors associated with HIV pathogenesis have also been implicated. This brief review provides an overview of the significance and complexities of HIV/ AIDS-related cardiovascular complications and addresses some important mechanistic aspects that may contribute to this important clinical problem.
| Original language | English |
|---|---|
| Pages (from-to) | 229-242 |
| Number of pages | 14 |
| Journal | Cardiovascular Toxicology |
| Volume | 4 |
| Issue number | 3 |
| DOIs | |
| State | Published - 2004 |
Keywords
- Cardiovascular
- Co-infectious pathogens
- HIV
- Oxidants
ASJC Scopus subject areas
- Molecular Biology
- Toxicology
- Cardiology and Cardiovascular Medicine